Encephalitis Pipeline Review, H2 2018 - Analysis by Stage of Development, Drug Target, MoA, RoA and Molecule Type - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Encephalitis - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Encephalitis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Encephalitis (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Encephalitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I and Preclinical stages are 1 and 6 respectively.
Encephalitis (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:Introduction Report Coverage Encephalitis - Overview Encephalitis - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Encephalitis - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Encephalitis - Companies Involved in Therapeutics Development CEL-SCI Corp Knight Therapeutics Inc Sage Therapeutics Inc For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/wp249n/encephalitis?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180925006114/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infectious Diseases Drugs
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/25/2018 03:27 PM/DISC: 09/25/2018 03:27 PM